Published in Medical Patent Law Weekly, November 22nd, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Sigma-Aldrich.
Report 1: Sigma-Aldrich Research Biotech, a division of Sigma-Aldrich (SIAL), has launched the PhosphoProfile I phosphopeptide enrichment kit, a new kit for the enrichment of phosphopeptides.
The technology is based on a novel Ga+3 chelate on silica that provides a robust method for phosphoproteomics. This new approach offers several advantages to proteomics researchers, including very low nonspecific binding, no bias in selectivity of phosphorylation state, high...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.